2. Yeo HJ, Oh DK, Yu WS, Choi SM, Jeon K, Ha M, et al. 2022; Outcomes of patients on the lung transplantation waitlist in Korea: a Korean Network for Organ Sharing data analysis. J Korean Med Sci. 37:e294. DOI:
10.3346/jkms.2022.37.e294. PMID:
36281485. PMCID:
PMC9592937.
Article
3. Yeo HJ, Kim DH, Kim YS, Jeon D, Cho WH. 2021; Performance changes following the revision of organ allocation system of lung transplant: analysis of Korean Network for Organ Sharing data. J Korean Med Sci. 36:e79. DOI:
10.3346/jkms.2021.36.e79. PMID:
33783144. PMCID:
PMC8007421.
Article
6. Snell GI, Yusen RD, Weill D, Strueber M, Garrity E, Reed A, et al. 2017; Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading: a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 36:1097–103. DOI:
10.1016/j.healun.2017.07.021. PMID:
28942784.
7. Venkata-Subramani M, Nunley DR, Roman J. 2021; Donor factors and risk of primary graft dysfunction and mortality post lung transplantation: a proposed conceptual framework. Clin Transplant. 35:e14480. DOI:
10.1111/ctr.14480. PMID:
34516007.
Article
8. Copeland H, Hayanga JW, Neyrinck A, MacDonald P, Dellgren G, Bertolotti A, et al. 2020; Donor heart and lung procurement: a consensus statement. J Heart Lung Transplant. 39:501–17. DOI:
10.1016/j.healun.2020.03.020. PMID:
32503726.
Article
9. Angel LF, Levine DJ, Restrepo MI, Johnson S, Sako E, Carpenter A, et al. 2006; Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med. 174:710–6. DOI:
10.1164/rccm.200603-432OC. PMID:
16799075.
Article
10. Plurad DS, Bricker S, Neville A, Bongard F, Putnam B. 2012; Arginine vasopressin significantly increases the rate of successful organ procurement in potential donors. Am J Surg. 204:856–60. DOI:
10.1016/j.amjsurg.2012.05.011. PMID:
23116641.
Article
12. Follette DM, Rudich SM, Babcock WD. 1998; Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 17:423–9.
13. Dhar R, Cotton C, Coleman J, Brockmeier D, Kappel D, Marklin G, et al. 2013; Comparison of high- and low-dose corticosteroid regimens for organ donor management. J Crit Care. 28:111.e1–7. DOI:
10.1016/j.jcrc.2012.04.015. PMID:
22762934.
Article
14. Callahan DS, Neville A, Bricker S, Kim D, Putnam B, Bongard F, et al. 2014; The effect of arginine vasopressin on organ donor procurement and lung function. J Surg Res. 186:452–7. DOI:
10.1016/j.jss.2013.09.028. PMID:
24176209.
Article
15. Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, et al. 2010; Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 304:2620–7. DOI:
10.1001/jama.2010.1796. PMID:
21156950.
Article
16. Son E, Jang J, Cho WH, Kim D, Yeo HJ. 2021; Successful lung transplantation after prone positioning in an ineligible donor: a case report. Gen Thorac Cardiovasc Surg. 69:1352–5. DOI:
10.1007/s11748-021-01676-4. PMID:
34159516. PMCID:
PMC8218964.
Article
17. Miñambres E, Coll E, Duerto J, Suberviola B, Mons R, Cifrian JM, et al. 2014; Effect of an intensive lung donor-management protocol on lung transplantation outcomes. J Heart Lung Transplant. 33:178–84. DOI:
10.1016/j.healun.2013.10.034. PMID:
24365763.
Article
18. Bobba CM, Whitson BA, Henn MC, Mokadam NA, Keller BC, Rosenheck J, et al. 2022; Trends in donation after circulatory death in lung transplantation in the United States: impact of era. Transpl Int. 35:10172. DOI:
10.3389/ti.2022.10172. PMID:
35444490. PMCID:
PMC9013720.
Article
20. Ali A, Wang A, Ribeiro RV, Beroncal EL, Baciu C, Galasso M, et al. 2021; Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function. Sci Transl Med. 13:eabf7601. DOI:
10.1126/scitranslmed.abf7601. PMID:
34524862.
Article